Free Trial

Inovio Pharmaceuticals (INO) Insider Trading & Ownership

Inovio Pharmaceuticals logo
$3.97 -0.06 (-1.49%)
(As of 11/20/2024 ET)

Inovio Pharmaceuticals (NASDAQ:INO) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
2.50%
Number Of
Insiders Buying
(Last 3 Years)
0
Number Of
Insiders Selling
(Last 3 Years)
2
Amount Of
Insider Selling
(Last 3 Years)
$83,986.56
Get INO Insider Trade Alerts

Want to know when executives and insiders are buying or selling Inovio Pharmaceuticals stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

INO Insider Buying and Selling by Quarter

Inovio Pharmaceuticals Insider and Congressional Trades History

Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
3/13/2023David B WeinerDirectorSell40$165.60$6,624.00  
2/27/2023David B WeinerDirectorSell81$184.32$14,929.92  
8/11/2022David B WeinerDirectorSell82$383.04$31,409.28  
7/20/2022Simon X BenitoDirectorSell13$324.00$4,212.00  
3/16/2022Simon X BenitoDirectorSell13$455.04$5,915.52  
3/14/2022David B WeinerDirectorSell28$460.80$12,902.40  
1/19/2022Simon X BenitoDirectorSell13$614.88$7,993.44  
(Data available from 1/1/2013 forward)

INO Insider Trading Activity - Frequently Asked Questions

The list of insiders at Inovio Pharmaceuticals includes David B Weiner, and Simon X Benito. Learn more on insiders at INO.

2.50% of Inovio Pharmaceuticals stock is owned by insiders. Learn more on INO's insider holdings.

The following insider sold INO shares in the last 24 months: David B Weiner ($21,553.92).

Insiders have sold a total of 121 Inovio Pharmaceuticals shares in the last 24 months for a total of $21,553.92 sold.

Inovio Pharmaceuticals Key Executives

  • Dr. Jacqueline E. Shea Ph.D. (Age 58)
    CEO, President & Director
    Compensation: $1.13M
  • Mr. Peter D. KiesMr. Peter D. Kies (Age 61)
    Chief Financial Officer
    Compensation: $810.2k
  • Dr. Laurent M. Humeau Ph.D. (Age 57)
    Chief Scientific Officer & Chairman of the Scientific Advisory Board
    Compensation: $794.08k
  • Thomas Hong
    Manager of Investor Relations
  • Mr. Robert L. Crotty J.D. (Age 50)
    General Counsel & Chief Compliance Officer
  • Mr. E. J. Brandreth MBA
    Senior Vice President of Quality Assurance
  • Dr. Jeffrey Skolnik
    Senior Vice President of Clinical Development
  • Mr. Robert J. Juba Jr.
    Senior Vice President of Biological Manufacturing & Clinical Supply Management
  • Mr. Stephen Kemmerrer M.B.A.
    P.E., Senior Vice President of Engineering Development
  • Mr. Shawn D. Bridy M.A.
    M.B.A., Senior Vice President of Business Development


This page (NASDAQ:INO) was last updated on 11/21/2024 by MarketBeat.com Staff
From Our Partners